 | • レポートコード：MRC2-11QY12963 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は血管炎治療薬のグローバル市場について調査・分析したレポートです。種類別（ブリシビモド、CCX-168、ゲボキズマブ、リツキシマブバイオシミラー、その他）市場規模、用途別（結節性多発動脈炎、血栓性血管炎、肉芽腫性血管炎、リンパ球性血管炎、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別血管炎治療薬の競争状況、市場シェア ・世界の血管炎治療薬市場：種類別市場規模 2015年-2020年（ブリシビモド、CCX-168、ゲボキズマブ、リツキシマブバイオシミラー、その他） ・世界の血管炎治療薬市場：種類別市場規模予測 2021年-2026年（ブリシビモド、CCX-168、ゲボキズマブ、リツキシマブバイオシミラー、その他） ・世界の血管炎治療薬市場：用途別市場規模 2015年-2020年（結節性多発動脈炎、血栓性血管炎、肉芽腫性血管炎、リンパ球性血管炎、その他） ・世界の血管炎治療薬市場：用途別市場規模予測 2021年-2026年（結節性多発動脈炎、血栓性血管炎、肉芽腫性血管炎、リンパ球性血管炎、その他） ・北米の血管炎治療薬市場分析：米国、カナダ ・ヨーロッパの血管炎治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの血管炎治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の血管炎治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの血管炎治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck、Bayer、Farmalider、Hainan Pharmaceutical Factory、Shanghaihuangxiang Lantian Pharmaceutical、Huzhou Konch Pharmaceutical、CSPC Ouyi Pharmaceutical、Sino-US Zibo Xinhua-Perrigo Pharmaceutical、Hubei Biocause Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Vasculitis Drug Market
The global Vasculitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Vasculitis Drug Scope and Market Size
Vasculitis Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Vasculitis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Vasculitis Drug market is segmented into
Blisibimod
CCX-168
Gevokizumab
Rituximab Biosimilar
Others
Segment by Application, the Vasculitis Drug market is segmented into
Polyarteritis Nodosa
Thrombotic Vasculitis
Granulomatous Vasculitis
Lymphocytic Vasculitis
Others
Regional and Country-level Analysis
The Vasculitis Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Vasculitis Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Vasculitis Drug Market Share Analysis
Vasculitis Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Vasculitis Drug business, the date to enter into the Vasculitis Drug market, Vasculitis Drug product introduction, recent developments, etc.
The major vendors covered:
Merck
Bayer
Farmalider
Hainan Pharmaceutical Factory
Shanghaihuangxiang Lantian Pharmaceutical
Huzhou Konch Pharmaceutical
CSPC Ouyi Pharmaceutical
Sino-US Zibo Xinhua-Perrigo Pharmaceutical
Hubei Biocause Pharmaceutical
1 Study Coverage
1.1 Vasculitis Drug Product Introduction
1.2 Market Segments
1.3 Key Vasculitis Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Vasculitis Drug Market Size Growth Rate by Type
1.4.2 Blisibimod
1.4.3 CCX-168
1.4.4 Gevokizumab
1.4.5 Rituximab Biosimilar
1.4.6 Others
1.5 Market by Application
1.5.1 Global Vasculitis Drug Market Size Growth Rate by Application
1.5.2 Polyarteritis Nodosa
1.5.3 Thrombotic Vasculitis
1.5.4 Granulomatous Vasculitis
1.5.5 Lymphocytic Vasculitis
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Vasculitis Drug Market Size, Estimates and Forecasts
2.1.1 Global Vasculitis Drug Revenue 2015-2026
2.1.2 Global Vasculitis Drug Sales 2015-2026
2.2 Global Vasculitis Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Vasculitis Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Vasculitis Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Vasculitis Drug Competitor Landscape by Players
3.1 Vasculitis Drug Sales by Manufacturers
3.1.1 Vasculitis Drug Sales by Manufacturers (2015-2020)
3.1.2 Vasculitis Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Vasculitis Drug Revenue by Manufacturers
3.2.1 Vasculitis Drug Revenue by Manufacturers (2015-2020)
3.2.2 Vasculitis Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Vasculitis Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Vasculitis Drug Revenue in 2019
3.2.5 Global Vasculitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Vasculitis Drug Price by Manufacturers
3.4 Vasculitis Drug Manufacturing Base Distribution, Product Types
3.4.1 Vasculitis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Vasculitis Drug Product Type
3.4.3 Date of International Manufacturers Enter into Vasculitis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Vasculitis Drug Market Size by Type (2015-2020)
4.1.1 Global Vasculitis Drug Sales by Type (2015-2020)
4.1.2 Global Vasculitis Drug Revenue by Type (2015-2020)
4.1.3 Vasculitis Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Vasculitis Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Vasculitis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Vasculitis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Vasculitis Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Vasculitis Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Vasculitis Drug Market Size by Application (2015-2020)
5.1.1 Global Vasculitis Drug Sales by Application (2015-2020)
5.1.2 Global Vasculitis Drug Revenue by Application (2015-2020)
5.1.3 Vasculitis Drug Price by Application (2015-2020)
5.2 Vasculitis Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Vasculitis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Vasculitis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Vasculitis Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Vasculitis Drug by Country
6.1.1 North America Vasculitis Drug Sales by Country
6.1.2 North America Vasculitis Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Vasculitis Drug Market Facts & Figures by Type
6.3 North America Vasculitis Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Vasculitis Drug by Country
7.1.1 Europe Vasculitis Drug Sales by Country
7.1.2 Europe Vasculitis Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Vasculitis Drug Market Facts & Figures by Type
7.3 Europe Vasculitis Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Vasculitis Drug by Region
8.1.1 Asia Pacific Vasculitis Drug Sales by Region
8.1.2 Asia Pacific Vasculitis Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Vasculitis Drug Market Facts & Figures by Type
8.3 Asia Pacific Vasculitis Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Vasculitis Drug by Country
9.1.1 Latin America Vasculitis Drug Sales by Country
9.1.2 Latin America Vasculitis Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Vasculitis Drug Market Facts & Figures by Type
9.3 Central & South America Vasculitis Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Vasculitis Drug by Country
10.1.1 Middle East and Africa Vasculitis Drug Sales by Country
10.1.2 Middle East and Africa Vasculitis Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Vasculitis Drug Market Facts & Figures by Type
10.3 Middle East and Africa Vasculitis Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Vasculitis Drug Products Offered
11.1.5 Merck Related Developments
11.2 Bayer
11.2.1 Bayer Corporation Information
11.2.2 Bayer Description and Business Overview
11.2.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bayer Vasculitis Drug Products Offered
11.2.5 Bayer Related Developments
11.3 Farmalider
11.3.1 Farmalider Corporation Information
11.3.2 Farmalider Description and Business Overview
11.3.3 Farmalider Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Farmalider Vasculitis Drug Products Offered
11.3.5 Farmalider Related Developments
11.4 Hainan Pharmaceutical Factory
11.4.1 Hainan Pharmaceutical Factory Corporation Information
11.4.2 Hainan Pharmaceutical Factory Description and Business Overview
11.4.3 Hainan Pharmaceutical Factory Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Hainan Pharmaceutical Factory Vasculitis Drug Products Offered
11.4.5 Hainan Pharmaceutical Factory Related Developments
11.5 Shanghaihuangxiang Lantian Pharmaceutical
11.5.1 Shanghaihuangxiang Lantian Pharmaceutical Corporation Information
11.5.2 Shanghaihuangxiang Lantian Pharmaceutical Description and Business Overview
11.5.3 Shanghaihuangxiang Lantian Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Products Offered
11.5.5 Shanghaihuangxiang Lantian Pharmaceutical Related Developments
11.6 Huzhou Konch Pharmaceutical
11.6.1 Huzhou Konch Pharmaceutical Corporation Information
11.6.2 Huzhou Konch Pharmaceutical Description and Business Overview
11.6.3 Huzhou Konch Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Huzhou Konch Pharmaceutical Vasculitis Drug Products Offered
11.6.5 Huzhou Konch Pharmaceutical Related Developments
11.7 CSPC Ouyi Pharmaceutical
11.7.1 CSPC Ouyi Pharmaceutical Corporation Information
11.7.2 CSPC Ouyi Pharmaceutical Description and Business Overview
11.7.3 CSPC Ouyi Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.7.4 CSPC Ouyi Pharmaceutical Vasculitis Drug Products Offered
11.7.5 CSPC Ouyi Pharmaceutical Related Developments
11.8 Sino-US Zibo Xinhua-Perrigo Pharmaceutical
11.8.1 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Corporation Information
11.8.2 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Description and Business Overview
11.8.3 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Products Offered
11.8.5 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Related Developments
11.9 Hubei Biocause Pharmaceutical
11.9.1 Hubei Biocause Pharmaceutical Corporation Information
11.9.2 Hubei Biocause Pharmaceutical Description and Business Overview
11.9.3 Hubei Biocause Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Hubei Biocause Pharmaceutical Vasculitis Drug Products Offered
11.9.5 Hubei Biocause Pharmaceutical Related Developments
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Vasculitis Drug Products Offered
11.1.5 Merck Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Vasculitis Drug Market Estimates and Projections by Region
12.1.1 Global Vasculitis Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Vasculitis Drug Revenue Forecast by Regions 2021-2026
12.2 North America Vasculitis Drug Market Size Forecast (2021-2026)
12.2.1 North America: Vasculitis Drug Sales Forecast (2021-2026)
12.2.2 North America: Vasculitis Drug Revenue Forecast (2021-2026)
12.2.3 North America: Vasculitis Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Vasculitis Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Vasculitis Drug Sales Forecast (2021-2026)
12.3.2 Europe: Vasculitis Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Vasculitis Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Vasculitis Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Vasculitis Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Vasculitis Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Vasculitis Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Vasculitis Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Vasculitis Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Vasculitis Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Vasculitis Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Vasculitis Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Vasculitis Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Vasculitis Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Vasculitis Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Vasculitis Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Vasculitis Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Vasculitis Drug Market Segments
Table 2. Ranking of Global Top Vasculitis Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Vasculitis Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Blisibimod
Table 5. Major Manufacturers of CCX-168
Table 6. Major Manufacturers of Gevokizumab
Table 7. Major Manufacturers of Rituximab Biosimilar
Table 8. Major Manufacturers of Others
Table 9. Global Vasculitis Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Vasculitis Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Vasculitis Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Vasculitis Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Vasculitis Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Vasculitis Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Vasculitis Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Vasculitis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Vasculitis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vasculitis Drug as of 2019)
Table 18. Vasculitis Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Vasculitis Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Vasculitis Drug Price (2015-2020) (USD/Pcs)
Table 21. Vasculitis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Vasculitis Drug Product Type
Table 23. Date of International Manufacturers Enter into Vasculitis Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Vasculitis Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Vasculitis Drug Sales Share by Type (2015-2020)
Table 27. Global Vasculitis Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Vasculitis Drug Revenue Share by Type (2015-2020)
Table 29. Vasculitis Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Vasculitis Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Vasculitis Drug Sales Share by Application (2015-2020)
Table 32. North America Vasculitis Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Vasculitis Drug Sales Market Share by Country (2015-2020)
Table 34. North America Vasculitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Vasculitis Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Vasculitis Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Vasculitis Drug Sales Market Share by Type (2015-2020)
Table 38. North America Vasculitis Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Vasculitis Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Vasculitis Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Vasculitis Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Vasculitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Vasculitis Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Vasculitis Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Vasculitis Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Vasculitis Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Vasculitis Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Vasculitis Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Vasculitis Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Vasculitis Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Vasculitis Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Vasculitis Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Vasculitis Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Vasculitis Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Vasculitis Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Vasculitis Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Vasculitis Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Vasculitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Vasculitis Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Vasculitis Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Vasculitis Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Vasculitis Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Vasculitis Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Vasculitis Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Vasculitis Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Vasculitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Vasculitis Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Vasculitis Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Vasculitis Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Vasculitis Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Vasculitis Drug Sales Market Share by Application (2015-2020)
Table 72. Merck Corporation Information
Table 73. Merck Description and Major Businesses
Table 74. Merck Vasculitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Merck Product
Table 76. Merck Recent Development
Table 77. Bayer Corporation Information
Table 78. Bayer Description and Major Businesses
Table 79. Bayer Vasculitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Bayer Product
Table 81. Bayer Recent Development
Table 82. Farmalider Corporation Information
Table 83. Farmalider Description and Major Businesses
Table 84. Farmalider Vasculitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Farmalider Product
Table 86. Farmalider Recent Development
Table 87. Hainan Pharmaceutical Factory Corporation Information
Table 88. Hainan Pharmaceutical Factory Description and Major Businesses
Table 89. Hainan Pharmaceutical Factory Vasculitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Hainan Pharmaceutical Factory Product
Table 91. Hainan Pharmaceutical Factory Recent Development
Table 92. Shanghaihuangxiang Lantian Pharmaceutical Corporation Information
Table 93. Shanghaihuangxiang Lantian Pharmaceutical Description and Major Businesses
Table 94. Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Shanghaihuangxiang Lantian Pharmaceutical Product
Table 96. Shanghaihuangxiang Lantian Pharmaceutical Recent Development
Table 97. Huzhou Konch Pharmaceutical Corporation Information
Table 98. Huzhou Konch Pharmaceutical Description and Major Businesses
Table 99. Huzhou Konch Pharmaceutical Vasculitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Huzhou Konch Pharmaceutical Product
Table 101. Huzhou Konch Pharmaceutical Recent Development
Table 102. CSPC Ouyi Pharmaceutical Corporation Information
Table 103. CSPC Ouyi Pharmaceutical Description and Major Businesses
Table 104. CSPC Ouyi Pharmaceutical Vasculitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. CSPC Ouyi Pharmaceutical Product
Table 106. CSPC Ouyi Pharmaceutical Recent Development
Table 107. Sino-US Zibo Xinhua-Perrigo Pharmaceutical Corporation Information
Table 108. Sino-US Zibo Xinhua-Perrigo Pharmaceutical Description and Major Businesses
Table 109. Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Sino-US Zibo Xinhua-Perrigo Pharmaceutical Product
Table 111. Sino-US Zibo Xinhua-Perrigo Pharmaceutical Recent Development
Table 112. Hubei Biocause Pharmaceutical Corporation Information
Table 113. Hubei Biocause Pharmaceutical Description and Major Businesses
Table 114. Hubei Biocause Pharmaceutical Vasculitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Hubei Biocause Pharmaceutical Product
Table 116. Hubei Biocause Pharmaceutical Recent Development
Table 117. Global Vasculitis Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 118. Global Vasculitis Drug Sales Market Share Forecast by Regions (2021-2026)
Table 119. Global Vasculitis Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 120. Global Vasculitis Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 121. North America: Vasculitis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 122. North America: Vasculitis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Europe: Vasculitis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 124. Europe: Vasculitis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Asia Pacific: Vasculitis Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 126. Asia Pacific: Vasculitis Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 127. Latin America: Vasculitis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 128. Latin America: Vasculitis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Middle East and Africa: Vasculitis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 130. Middle East and Africa: Vasculitis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 132. Key Challenges
Table 133. Market Risks
Table 134. Main Points Interviewed from Key Vasculitis Drug Players
Table 135. Vasculitis Drug Customers List
Table 136. Vasculitis Drug Distributors List
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Vasculitis Drug Product Picture
Figure 2. Global Vasculitis Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Blisibimod Product Picture
Figure 4. CCX-168 Product Picture
Figure 5. Gevokizumab Product Picture
Figure 6. Rituximab Biosimilar Product Picture
Figure 7. Others Product Picture
Figure 8. Global Vasculitis Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Polyarteritis Nodosa
Figure 10. Thrombotic Vasculitis
Figure 11. Granulomatous Vasculitis
Figure 12. Lymphocytic Vasculitis
Figure 13. Others
Figure 14. Vasculitis Drug Report Years Considered
Figure 15. Global Vasculitis Drug Market Size 2015-2026 (US$ Million)
Figure 16. Global Vasculitis Drug Sales 2015-2026 (K Pcs)
Figure 17. Global Vasculitis Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Vasculitis Drug Sales Market Share by Region (2015-2020)
Figure 19. Global Vasculitis Drug Sales Market Share by Region in 2019
Figure 20. Global Vasculitis Drug Revenue Market Share by Region (2015-2020)
Figure 21. Global Vasculitis Drug Revenue Market Share by Region in 2019
Figure 22. Global Vasculitis Drug Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Vasculitis Drug Revenue in 2019
Figure 24. Vasculitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Vasculitis Drug Sales Market Share by Type (2015-2020)
Figure 26. Global Vasculitis Drug Sales Market Share by Type in 2019
Figure 27. Global Vasculitis Drug Revenue Market Share by Type (2015-2020)
Figure 28. Global Vasculitis Drug Revenue Market Share by Type in 2019
Figure 29. Global Vasculitis Drug Market Share by Price Range (2015-2020)
Figure 30. Global Vasculitis Drug Sales Market Share by Application (2015-2020)
Figure 31. Global Vasculitis Drug Sales Market Share by Application in 2019
Figure 32. Global Vasculitis Drug Revenue Market Share by Application (2015-2020)
Figure 33. Global Vasculitis Drug Revenue Market Share by Application in 2019
Figure 34. North America Vasculitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Vasculitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Vasculitis Drug Sales Market Share by Country in 2019
Figure 37. North America Vasculitis Drug Revenue Market Share by Country in 2019
Figure 38. U.S. Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Vasculitis Drug Market Share by Type in 2019
Figure 43. North America Vasculitis Drug Market Share by Application in 2019
Figure 44. Europe Vasculitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Vasculitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Vasculitis Drug Sales Market Share by Country in 2019
Figure 47. Europe Vasculitis Drug Revenue Market Share by Country in 2019
Figure 48. Germany Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Vasculitis Drug Market Share by Type in 2019
Figure 59. Europe Vasculitis Drug Market Share by Application in 2019
Figure 60. Asia Pacific Vasculitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Vasculitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Vasculitis Drug Sales Market Share by Region in 2019
Figure 63. Asia Pacific Vasculitis Drug Revenue Market Share by Region in 2019
Figure 64. China Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Vasculitis Drug Market Share by Type in 2019
Figure 87. Asia Pacific Vasculitis Drug Market Share by Application in 2019
Figure 88. Latin America Vasculitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Vasculitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Vasculitis Drug Sales Market Share by Country in 2019
Figure 91. Latin America Vasculitis Drug Revenue Market Share by Country in 2019
Figure 92. Mexico Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Vasculitis Drug Market Share by Type in 2019
Figure 99. Latin America Vasculitis Drug Market Share by Application in 2019
Figure 100. Middle East and Africa Vasculitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Vasculitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Vasculitis Drug Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Vasculitis Drug Revenue Market Share by Country in 2019
Figure 104. Turkey Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Vasculitis Drug Market Share by Type in 2019
Figure 111. Middle East and Africa Vasculitis Drug Market Share by Application in 2019
Figure 112. North America Vasculitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Vasculitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Vasculitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Vasculitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Vasculitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Vasculitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Vasculitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Vasculitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Vasculitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Vasculitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
ANCA関連血管炎薬の世界市場（～2026年） Market Analysis and Insights: Global Anca Vasculitis Drug Market The global Anca Vasculitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anca Vasculitis Drug Scope and Market Size Anca Vasculitis Drug market is…- 血管炎治療の世界市場（～2026年） Vasculitis is a general term that refers to inflammation of blood vessels. When blood vessels become inflamed, they may become weakened, stretch, and either increase in size or become narrow -- even to the point of closing entirely. Vasculitis can affect people of all ages, but there are types of va…
- 小売薬の世界市場（～2026年） A drug is any substance (other than food that provides nutritional support) that, when inhaled, injected, smoked, consumed, absorbed via a patch on the skin, or dissolved under the tongue causes a temporary physiological (and often psychological) change in the body. Increasing industry share of Asia…
- ドラッグリポジショニングの世界市場（～2026年） Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositione…
- 乱用薬物検査サービスの世界市場（～2026年） Drug of Abuse Testing Services is the use of testing services to avoid the negative effects of drug abuse, to reduce the accidents. In addition to rise in number of substance abusers and increase in number of government initiatives to avoid ill effects of substance abuse at workplace & reduce number…